Computed Tomography (CT) Colonography Systems Market Global Report 2026

The computed tomography (CT) colonography systems market size has grown strongly in recent years. It will grow from $1.12 billion in 2025 to $1.22 billion in 2026 at a compound annual growth rate (CAGR) of 8.9%. The growth in the historic period can be attributed to rising prevalence of colorectal disorders, increasing awareness regarding early cancer detection, growing adoption of advanced diagnostic imaging technologies, expansion of healthcare infrastructure facilities, increasing demand for non-invasive diagnostic procedures.

The computed tomography (CT) colonography systems market size is expected to see strong growth in the next few years. It will grow to $1.69 billion in 2030 at a compound annual growth rate (CAGR) of 8.5%. The growth in the forecast period can be attributed to rising demand for precision diagnostic solutions, increasing integration of AI-assisted imaging technologies, growing investments in advanced healthcare imaging infrastructure, increasing implementation of preventive screening programs, expansion of diagnostic services in emerging healthcare markets. Major trends in the forecast period include increasing adoption of non-invasive colorectal screening procedures, growing demand for low-radiation imaging technologies, rising preference for early disease detection and preventive diagnostics, increasing utilization of high-resolution imaging systems, growing demand for improved diagnostic accuracy in gastrointestinal disorders.

The increasing prevalence of colorectal cancer is expected to drive the growth of the computed tomography (CT) colonography systems market going forward. Colorectal cancer is a type of cancer that begins in the colon or rectum and typically develops from abnormal growths known as polyps in the lining of the large intestine. The rising prevalence of colorectal cancer is driven by unhealthy dietary habits, including low fiber intake, high consumption of processed and red meats, and sedentary lifestyles, which collectively increase the risk of developing the disease over time. Computed tomography (CT) colonography systems support colorectal cancer diagnosis by enabling non-invasive, high-resolution imaging of the colon to detect polyps and early-stage malignancies, thereby improving early diagnosis and timely clinical intervention. For instance, in August 2025, according to the American Cancer Society, a US-based nonprofit organization, the total number of patients screened for colorectal cancer (CRC) increased to 3,617,246 in 2024, compared with 3,306,873 in 2023. Therefore, the increasing prevalence of colorectal cancer is driving the growth of the computed tomography (CT) colonography systems market.

The rising preference for non-invasive diagnostic procedures is expected to drive the growth of the computed tomography (CT) colonography systems market going forward. Non-invasive diagnostic procedures refer to medical tests and imaging techniques that evaluate, detect, or monitor diseases without requiring incisions, tissue removal, or entry into the body. The growing preference for non-invasive diagnostic procedures is primarily driven by increasing demand for safer diagnostic techniques that reduce patient discomfort. The rising preference for non-invasive diagnostic procedures supports the adoption of computed tomography (CT) colonography systems by increasing demand for safer and more comfortable colorectal cancer screening alternatives to traditional invasive colonoscopy. For instance, in November 2024, according to the National Health Service, a UK-based public health service provider, in 2023 to 2024, a total of 11.4 million tests potentially used to diagnose or rule out cancer were carried out, marking a 2.8% increase from the 11.1 million tests conducted in 2022 to 2023. During the same period, chest X-ray referrals increased by 1.4%, while pelvic ultrasound and kidney ultrasound volumes rose by 5.1% and 1.3%, respectively. Therefore, the rising preference for non-invasive diagnostic procedures is driving the growth of the computed tomography (CT) colonography systems market.

In November 2024, Bracco Imaging S.p.A., an Italy-based medical imaging company specializing in contrast agents and diagnostic imaging solutions, partnered with Colowatch to expand access to virtual colonoscopy services. Through this partnership, Bracco Imaging and Colowatch aim to enhance the adoption of computed tomography (CT) colonography systems by combining advanced imaging support with software-driven virtual colonoscopy workflows to improve early colorectal cancer detection, increase screening efficiency, and enable more accessible non-invasive diagnostic procedures. ColoWatch is a US-based healthcare technology and screening program that provides an AI-powered virtual colonoscopy (CT colonography) service.

Major companies operating in the computed tomography (ct) colonography systems market are Siemens Healthineers AG; GE HealthCare Technologies Inc.; Koninklijke Philips N.V.; Canon Medical Systems Corporation; Fujifilm Holdings Corporation; Sectra AB; Visage Imaging Inc.; United Imaging Healthcare Co Ltd.; Neusoft Medical Systems Co Ltd.; Viatronix; Bracco Imaging S.p.A.; Agfa-Gevaert Group; Trivitron Healthcare; ColoWatch; Intelerad Medical Systems Incorporated; iCAD Inc.; DeepHealth Inc.; Medicsight PLC.

North America was the largest region in the computed tomography (CT) colonography systems market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the computed tomography (CT) colonography systems market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the computed tomography (CT) colonography systems market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The computed tomography (CT) colonography systems market consists of sales of cone-beam CT systems, 3D visualization and advanced imaging workstations, radiology information systems, contrast media injectors, and medical imaging contrast agents. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The computed tomography (ct) colonography systems market research report is one of a series of new reports that provides computed tomography (ct) colonography systems market statistics, including computed tomography (ct) colonography systems industry global market size, regional shares, competitors with a computed tomography (ct) colonography systems market share, detailed computed tomography (ct) colonography systems market segments, market trends and opportunities, and any further data you may need to thrive in the computed tomography (ct) colonography systems industry. This computed tomography (ct) colonography systems market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

This product will be delivered within 1-3 business days.